Chantal Combredet
Overview
Explore the profile of Chantal Combredet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
865
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vera-Peralta H, Ruffie C, Najburg V, Brione M, Combredet C, Frantz P, et al.
Hum Vaccin Immunother
. 2024 Dec;
20(1):2436241.
PMID: 39693193
Measles live attenuated vaccine (MV) induces strong humoral and cellular systemic memory responses allowing the successful control of measles since decades. MV has also been adapted into a promising vaccine...
2.
Chatelain C, Berland L, Grard M, Jouand N, Fresquet J, Nader J, et al.
Oncoimmunology
. 2024 Jul;
13(1):2377830.
PMID: 39005546
Attenuated measles virus (MV) exerts its oncolytic activity in malignant pleural mesothelioma (MPM) cells that lack type-I interferon (IFN-I) production or responsiveness. However, other cells in the tumor microenvironment (TME),...
3.
Vera-Peralta H, Najburg V, Combredet C, Douche T, Giai Gianetto Q, Matondo M, et al.
Methods Mol Biol
. 2024 May;
2808:89-103.
PMID: 38743364
The study of virus-host interactions is essential to achieve a comprehensive understanding of the viral replication process. The commonly used methods are yeast two-hybrid approach and transient expression of a...
4.
Grard M, Idjellidaine M, Arbabian A, Chatelain C, Berland L, Combredet C, et al.
Cancer Immunol Immunother
. 2023 Jul;
72(10):3309-3322.
PMID: 37466668
Antitumor virotherapy stimulates the antitumor immune response during tumor cell lysis induced by oncolytic viruses (OVs). OV can be modified to express additional transgenes that enhance their therapeutic potential. In...
5.
Khalfi P, Suspene R, Raymond K, Caval V, Caignard G, Berry N, et al.
PLoS Pathog
. 2023 Feb;
19(2):e1011170.
PMID: 36802406
Viruses have evolved countless mechanisms to subvert and impair the host innate immune response. Measles virus (MeV), an enveloped, non-segmented, negative-strand RNA virus, alters the interferon response through different mechanisms,...
6.
Frantz P, Barinov A, Ruffie C, Combredet C, Najburg V, de Melo G, et al.
Nat Commun
. 2021 Nov;
12(1):6277.
PMID: 34725327
Several COVID-19 vaccines have now been deployed to tackle the SARS-CoV-2 pandemic, most of them based on messenger RNA or adenovirus vectors.The duration of protection afforded by these vaccines is...
7.
Nzounza P, Martin G, Dereuddre-Bosquet N, Najburg V, Gosse L, Ruffie C, et al.
NPJ Vaccines
. 2021 Oct;
6(1):123.
PMID: 34686669
Replicative vectors derived from live-attenuated measles virus (MV) carrying additional non-measles vaccine antigens have long demonstrated safety and immunogenicity in humans despite pre-existing immunity to measles. Here, we report the...
8.
Meignie A, Combredet C, Santolini M, Kovacs I, Douche T, Giai Gianetto Q, et al.
Mol Cell Proteomics
. 2021 Jan;
20:100049.
PMID: 33515806
Viruses manipulate the central machineries of host cells to their advantage. They prevent host cell antiviral responses to create a favorable environment for their survival and propagation. Measles virus (MV)...
9.
Sanchez David R, Combredet C, Najburg V, Millot G, Beauclair G, Schwikowski B, et al.
Sci Signal
. 2019 Oct;
12(601).
PMID: 31575732
The retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) RIG-I, MDA5, and LGP2 stimulate inflammatory and antiviral responses by sensing nonself RNA molecules produced during viral replication. Here, we investigated how...
10.
Mura M, Ruffie C, Combredet C, Aliprandini E, Formaglio P, Chitnis C, et al.
NPJ Vaccines
. 2019 Mar;
4:12.
PMID: 30820355
Following the RTS,S malaria vaccine, which showed only partial protection with short-term memory, there is strong support to develop second-generation malaria vaccines that yield higher efficacy with longer duration. The...